Back to search

Article

Serum profiles of metabolomic and GDF-15 differentiate idiopathic pulmonary fibrosis from other interstital lung diseases: a preliminary study

2022-03-22

Abstract excerpt

<h4>Objective: </h4> 1. Explore the differential metabolites and metabolic pathways between different interstitial lung disease (ILD) and healthy controls, so as to find out new biomarkers and metabolic pathways of ILD and provide new biological targets for IPF diagnosis and treatment. 2. Detect the levels of serum related fibrosis and metabolic indexes of ILD, explore the relationship between these indexes and th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2fbeaeb8-56f4-533f-8c39-41d945d02bfa
DOI
10.1101/2022.03.22.484740
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serum profiles of metabolomic and GDF-15 differentiate idiopathic pulmonary fibrosis from other interstital lung diseases: a preliminary studyDOI 10.1101/2022.03.22.484740
Distinct Metabolic Signatures Linked to High-Resolution Computed Tomography Radiographic Phenotypes in Stable and Progressive Fibrotic Lung DiseaseSemantic proximity
Metabolomic profiling reveals distinct metabolic patterns and a potential circulating biomarker in pre-COPDSemantic proximity
Bioinformatic analyses and integrated machine learning reveal the role of lactate, a metabolic driver of the immune landscape, serves in idiopathic pulmonary fibrosisSemantic proximity
Multi-omics study on biomarker and pathway discovery of chronic obstructive pulmonary diseaseSemantic proximity
Metabolic profiling of patients with different idiopathic inflammatory myopathy subtypes reveals potential biomarkers in plasmaSemantic proximity
Serum Proteomics Identifies Biomarkers Associated With the Pathogenesis of Idiopathic Pulmonary FibrosisSemantic proximity
Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPCSemantic proximity
Metagenomic next-generation sequencing for pathogenic diagnosis in patients with acute exacerbation of interstitial lung diseaseSemantic proximity
Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and 'frequent exacerbator' phenotype.Semantic proximity
Identification of amino acid metabolism-related biomarkers in liver fibrosis: a transcriptomic analysis with experimental validationSemantic proximity
Using omics approaches to understand pulmonary diseasesSemantic proximity
Novel Lipidomes Profile and Clinical Phenotype Identified in Pneumoconiosis PatientsSemantic proximity
Select a neighboring publication to make it the new centre.